Pharmaceuticals, Biotechnology and Life Sciences
Neovacs’s Scientific Advisory Board has recommended extension of the development of IFN Kinoid to a new indication, Type 1 Diabetes, with the objectives of obtaining preclinical proof of concept in 2017 and initiating clinical development for this program in the first half of 2018.
Novartis delivered a solid performance in 2016, absorbing Gleevec US loss of exclusivity while investing in key launches and the Alcon Division turnaround
TxCell has moved into action to raise some money, as it wants to raise gross proceeds of about €11 million by issuing new shares with warrants attached.
The deal InnovaDerma had with PROS International Company of Korea to sell InnovaDerma products in a terrotiroy of S Korea, Japan, China and Russia has breaken apart, the UK based maker of hair and skin care products said on Wednesday.
Biocorp, a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, has announced it will be part of the 20th edition of Pharmapack exhibition, which will take place on 1st-2ndFebruary 2017, in Paris (France).
Hikma Pharmaceuticals participated in the World Economic Forum (WEF) Annual Meeting in Davos, Switzerland, held between 17 and 20 January,…
Probi, Swedish bioengineering company that develops probiotics has reported Q4 2016 financial results.
Horizon Discovery Group expects to see 2016 revenues rise for about 20%, as it expects revenue of at least £24.0 million.
Quantum Pharma, has granted options over 1,100,000 Ordinary Shares of 10 pence each (‘Ordinary Shares’) with an exercise price of 30 pence, to Gerard Murray, Chief Financial Officer.
Nicox, the international ophthalmic R&D company, has provided certain regulatory and clinical updates for NCX 470, its novel nitric oxide…